Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Diabetic retinopathy (DR) is a major complication of diabetes and a leading cause of blindness worldwide. DR was recently defined as a neurovascular disease associated with tissue-specific neurovascular impairment of the retina in patients with diabetes. Neurovascular cell death is the main cause of neurovascular impairment in DR. Thus, neurovascular cell protection is a potential therapy for preventing the progression of DR. Growing evidence indicates that a variety of cell death pathways, such as apoptosis, necroptosis, ferroptosis, and pyroptosis, are associated with neurovascular cell death in DR. These forms of regulated cell death may serve as therapeutic targets for ameliorating the pathogenesis of DR. This review focuses on these cell death mechanisms and describes potential therapies for the treatment of DR that protect against neurovascular cell death.
Oshitari T Int J Mol Sci. 2024; 25(19).
PMID: 39408817 PMC: 11476551. DOI: 10.3390/ijms251910485.
Wang Y, Song S, Song Y, Wang Y, Wan Z, Sun P Mol Neurobiol. 2024; 62(3):3412-3427.
PMID: 39292340 DOI: 10.1007/s12035-024-04496-8.
Peptain-1 blocks ischemia/reperfusion-induced retinal capillary degeneration in mice.
Nam M, Dhillon A, Nahomi R, Carrillo N, Hougen C, Nagaraj R Front Cell Neurosci. 2024; 18:1441924.
PMID: 39149168 PMC: 11324586. DOI: 10.3389/fncel.2024.1441924.
Sheng X, Zhang C, Zhao J, Xu J, Zhang P, Ding Q Cell Biosci. 2024; 14(1):85.
PMID: 38937783 PMC: 11212265. DOI: 10.1186/s13578-024-01269-7.
Rejuvenation of diabetic macular edema with senolytic therapy.
Murakami T, Gardner T Nat Med. 2024; 30(2):346-347.
PMID: 38332040 DOI: 10.1038/s41591-024-02804-2.